Rebuild Drugs Private Limited Company Logo

Rebuild Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Hanuman Nagar, Bihar, India, established in 2012.

2012 | Hanuman Nagar, Bihar, India | Struck Off
Last Updated:

About Rebuild Drugs Private Limited

Rebuild Drugs Private Limited, a struck off private limited company, was established on 31 August 2012 in Hanuman Nagar, Bihar, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232BR2012PTC019168. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Shyam Sunder Kumar (Director), Neeraj Kumar (Director). It is based at Vina Shyam Niketan H/No-272,Darika Puri,Road No-2, Hanuman Nagar, Bihar, 800020.

Company Details

  • CIN/LLPIN

    U24232BR2012PTC019168

  • Registration Number

    019168

  • Incorporation Date

    31 August 2012

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Patna

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Indicators

  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 3 Months
Company report

Rebuild Drugs Private Limited

Company Report FY 2025-2026

Explore comprehensive insights into Rebuild Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element

Who are the key members and board of directors at Rebuild Drugs Private Limited?

Current Directors

NameDesignationAppointment DateStatus
Shyam Sunder KumarDirector31 Aug 2012Current
Neeraj KumarDirector31 Aug 2012Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rebuild Drugs.

Enhance accessibility to Rebuild Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Rebuild Drugs revenue growth over time
Rebuild Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Rebuild Drugs?

Unlock access to Rebuild Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

There are no open charges registered against the company as per our records.

How Many Employees Work at Rebuild Drugs?

Unlock and access historical data on people associated with Rebuild Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Rebuild Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rebuild Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rebuild Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rebuild Drugs

Recent Activity within the Organization

  • Director Appointment

    Shyam Sunder Kumar was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.

  • Director Appointment

    Neeraj Kumar was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Rebuild Drugs Private Limited was registered on 31 Aug 2012 with Roc Patna & aged 13 years 3 months as per MCA records. was documented.

Frequently Asked Questions

  • What is the CIN of Rebuild Drugs Private Limited?

    The CIN of Rebuild Drugs Private Limited is U24232BR2012PTC019168.

  • Where is Rebuild Drugs Private Limited headquartered?

    Rebuild Drugs Private Limited is headquartered at Vina Shyam Niketan H/No-272,Darika Puri,Road No-2, Hanuman Nagar, Bihar, 800020.

  • When was Rebuild Drugs Private Limited incorporated?

    Rebuild Drugs Private Limited was incorporated on 31 August 2012.

  • Who are the current directors of Rebuild Drugs Private Limited?

    The current directors of Rebuild Drugs Private Limited are

  • What is the primary industry of Rebuild Drugs Private Limited?

    The primary industry of Rebuild Drugs Private Limited is Chemicals.

  • Is Rebuild Drugs Private Limited a listed company?

    Rebuild Drugs Private Limited is unlisted.

  • What is the capital structure of Rebuild Drugs Private Limited?

    The authorized capital of Rebuild Drugs Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.

  • What is the compliance status of Rebuild Drugs Private Limited?

    The compliance status of Rebuild Drugs Private Limited is Active Non-Compliant.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial